Advice Pool
#1 in Business Subscribe Email Print

You are here: Home > Reference and Education > Psychology > Cocktails, Neurons and Nanos: Super-Cognition?

Tags

  • still
  • alertness
  • patients
  • combination products

  • Links

  • Golf Course Bunker Design
  • Themes for Your Baby Nursery - Frog Themed Bedding
  • Low-Priced, Warm North Carolina Tops The List For Retirees
  • Advice Pool - Cocktails, Neurons and Nanos: Super-Cognition?

    Improving overall cognitive capability is becoming as simple as consuming a pill...

    An interesting paradox has been the axis of much attention in the fields of pharmacy, brain research and ethics in the last few years. The advent of new technologies, particularly in the field of brain research, has induced scientists to improve the trea
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    tment of several conditions, such as Alzheimer’s disease, sleep disorders and dementia. However, what was primarily intentioned to provide solutions for patients with cognitive deficits has also proven functional for healthy people – not only functional, but quite efficient.

    The human brain consists of 100 billion neurons linked in around 100
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    rillion connections. This large number is possibly due to the parallel nature of brain connections, and the multi-layered strucuture in which our most notable organ is organised. New classes of drugs - particularly ‘Ampakines’ - are exploring ways to achieve cognitive improvements whilst moderating the incidence of side effects. Albeit designed
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    for combating the effects of degenerative diseases, these cognitive enhancers have increasingly gained popularity as a competitive advantage for students, executives and people who simply want to exceed their own limitations.

    Ampakines

    Ampakines are a class of drugs which name is originated from the AMPA receptor (protein). These recep
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    tors play a major role in the encoding of many types of memory and in inducing excitatory communication in the brain (which increases levels of glutamate-mediated communication). Because glutamate is our predominant neurotransmitter, drugs which manipulate the levels of glutamate can considerably improve cognitive skills by improving neural com
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    unication.

    “Nerve cells (neurons) in the brain communicate with each other by releasing small molecules know as neurotransmitters. These neurotransmitters bind to proteins, called receptors, located on the surface of the receiving neurons. This binding then triggers subsequent cellular events in these neurons” (Cortex Research (www.cortexpharm
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    com/html/research/tech.html)).

    Ampakines can provide a variety of results, often improving cognitive functions such as attention, alertness and memory.

    No Need for Disease

    The potential for improving memory, concentration and other important cognitive skills has been initially observed by pharmaceutical companies and military research
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    . Nowadays, most large drug producers in the world are on their way to test Ampakines, and other ‘cognitive enhancing’ drug types. The military has performed several trials and it is particularly interested in the alertness effects of Ampakines, such as CX717 (developed by Cortex Pharmaceuticals). This drug could be a solution for jet pilots or
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    special operation forces to remain alert for several days during combats – no need for much sleep, and apparently very few side effects (unlike amphetamines, caffeine and other substances which were commonly used for such purpose). At this stage, the general public has also become aware of the ‘wonders’ of such drugs, and the popularity among s
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    udents, executives and other professionals has increased immensely - such that many are diagnosed with some ‘broad-diagnosing’ diseases in order to obtain medical scripts for purchase. Consumers also use diagnosed friends to access the medicines, buy it from the internet under false allegations, or simply opt for the black market.

    Other drug t
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    pes, such as Mem compounds, are also being developed and undertaking trials. Although the pharmaceutical companies are producing these drugs for the treatment of varied mental conditions, it is increasingly noticeable that their popularity among superman-aspirants is producing a significant raise in revenue for major producers. Along with the e
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    xpected advances in technology, ethical issues are stirring among specialists – are these drug cocktails really a good option to achieve better performance?

    Future or Science Fiction?

    This question is multi-faceted and particularly interesting. However, there may not be a long-term need for such discussion. Progressive development in b
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ain research over the last few years is inducing many experts and scientists to reach for new paradigms. The exponential growth of technology is allowing brain scanning techniques to become quite powerful, and this has been used to initiate a series of cross-discipline experiments – such as the use of nanotechnology and reverse engineering in b
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ain research.

    But it does not stop there. Currently, a project entitled the ‘Human Connectome’ (cited in a previous article) is attempting to create a 4-dimensional map of all brain functions, while advances in physics will eventually allow further access to the mysteries of the human mind. With that in mind, experts such as Ray Kurzweil – aut
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    hor and scientist – predict that the human cognitive capacity will achieve enormous progress through a mix of gene manipulation and the use of artificial systems input (such as nanotechnology). These artificial systems would act as regenerative tools for damaged cells and tissues, neural communication enhancers (by converting analog communicati
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    n into digital – thus achieving much higher processing speeds), and many other purposes. The advent of such technologies could convert pills and doses into obsolete cognitive tools.

    In the end, the quest for superman-cognition is a matter of patience as much research is either incomplete, or uncertain. Indeed we are stepping in a new era – but
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    the outcomes of this experience are still beyond the grasp of our human civilization.

    Did You Know?

    1) “The Brain’s circuits are very slow. Synaptic-reset and neuron-stabilization times (the amount of time required for a neuron and its synapses to reset themselves after the neuron fires) are so slow that there are very few neuron-firi
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ng cycles available to make pattern-recognition decisions. Functional magnetic-resonance imaging (fMRI) and magneto-encephalography (MEG) scans show that judgements that do not require resolving ambiguities appear to be made in a single neuron-firing cycle (less than twenty milliseconds), involving essentially no iterative (repeated) processes.
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    Recognition of objects occurs in about 150 milliseconds, so that even if we “think something over”, the number of cycles of operation is measured in hundreds or thousands at most, not billions, as with a typical computer.” (Ray Kurzweil – “The Singularity is Near”, 2005, page 150)

    2) “Approximately 20% of the blood flowing from the heart is p
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    mped to the brain. The brain needs constant blood flow in order to keep up with the heavy metabolic demands of the neurons. Brain imaging techniques such as functional magnetic resonance imaging (fMRI) rely on this relationship between neural activity and blood flow to produce images of reduced brain activity.” (http://www.brainetwork-usm.org


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.advicepool.org.ua/article/222237/advicepool-Cocktails-Neurons-and-Nanos-SuperCognition.html">Cocktails, Neurons and Nanos: Super-Cognition?</a>

    BB link (for phorums):
    [url=http://www.advicepool.org.ua/article/222237/advicepool-Cocktails-Neurons-and-Nanos-SuperCognition.html]Cocktails, Neurons and Nanos: Super-Cognition?[/url]

    Related Articles:

    You Can't Flip if the Property Won't Move

    Global Warming? Pah!

    Writing A College Term Paper

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com